Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
592 days ago
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
858 days ago
U.S. Dollar Rises After Nonfarm Payrolls Data, Fed Chair Jerome Powell's Speech
The U.S. dollar advanced against its major counterparts in the New York session on Friday, as traders cheered Federal Reserve Chair Jerome Powell's comments and solid jobs data for March.
RTTNews
|
5h 29min ago
Swiss Market Ends Sharply Lower On Trade War Fears
Swiss stocks fell sharply on Friday, mirroring losses across Europe and elsewhere, as the Trump Administration's sweeping tariffs on trade partners, and retaliatory move announced by China, and possible countermeasures by a few other major countries as well, raised fears of a possible global recession.
RTTNews
|
8h 11min ago
European Stocks Tumble As China Retaliates After Trump's Tariff Moves
European stocks plunged sharply and several market tumbled to fresh multi-month lows on Friday as U.S. President Donald Trump's sweeping tariff moves, and the retaliatory action by China raised fears of a global trade war and recession, prompting investors to press sales across the board.
RTTNews
|
8h 31min ago
Canadian Market Remains Deep Down In Negative Territory After Another Bloodbath
It's a bloodbath on Bay Street again with the stocks seeing a free fall amid rising fears of a global recession following U.S. President Donald Trump's sweeping "reciprocal tariffs" moves and the retaliatory move by China raising concerns about economic growth.
RTTNews
|
9h 10min ago
Powell Says Tariffs Likely To Lead To Higher Inflation, Slower Growth
Citing a highly uncertain outlook due in part to President Donald Trump's new tariffs, Federal Reserve Chair Jerome Powell on Friday indicated the central bank will wait for greater clarity before considering any adjustments to interest rates.
RTTNews
|
9h 37min ago
CPSC Recalls: Polaris ROVs, Accessory Heaters, Window Hinge Tracks, Bear Lights, Propane Heaters
The U.S. Consumer Product safety Commission or CPSC has announced various recalls including Polaris Recreational Off-Road Vehicles or ROVs, Honda accessory heaters, high chairs, window hinge tracks, baby bath seats, bear lights, and propane heaters, among others.
RTTNews
|
11h 41min ago
